TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bristol-Myers Squibb Norway AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
198,288
|
166,489
|
519,938 |
Financial expenses |
367
|
523
|
1,320 |
Earnings before taxes |
9,763
|
8,432
|
24,288 |
Total assets |
264,604
|
266,094
|
288,369 |
Current assets |
264,265
|
265,937
|
288,169 |
Current liabilities |
58,620
|
54,661
|
90,334 |
Equity capital |
205,984
|
211,433
|
198,035 |
- share capital |
987
|
846
|
820 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.8%
|
79.5%
|
68.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.9%
|
5.1%
|
4.7% |
Return on assets (ROA) |
3.8%
|
3.4%
|
8.9% |
Current ratio |
450.8%
|
486.5%
|
319.0% |
Return on equity (ROE) |
4.7%
|
4.0%
|
12.3% |
Change turnover |
42,830
|
-369,559
|
24,526 |
Change turnover % |
28%
|
-69%
|
5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.